Last 12 months
Inside the activity.
0 purchase rows · 91 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 16 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 07, 2026 Filed Jul 9, 2026 23:35 UTC |
Yu Jonathan Yen-WenChief Operating Officer
|
Exercise / conversionCommon Stock | 100 | $13.50 | $1,350.00 |
DisclosureSEC source: 0001193125-26-299954 · ownership.xml · nonDerivative · entry 1 Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026. Read SEC document |
| June 29, 2026 Filed Jun 30, 2026 21:49 UTC |
Khara RahulChief Legal Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,649 | $0.00 Strike: $14.69 | $0.00 |
DisclosureSEC source: 0001193125-26-290902 · ownership.xml · derivative · entry 6 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,804 Underlying: Common Stock · 1,649 shares Expires 2032-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| June 29, 2026 Filed Jun 30, 2026 21:49 UTC |
Khara RahulChief Legal Officer
|
SaleCommon Stock | 1,649 | $75.00 | $123,675.00 |
DisclosureSEC source: 0001193125-26-290902 · ownership.xml · nonDerivative · entry 4 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,173 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. Read SEC document |
| June 29, 2026 Filed Jun 30, 2026 21:49 UTC |
Khara RahulChief Legal Officer
|
Exercise / conversionCommon Stock | 1,649 | $14.69 | $24,223.81 |
DisclosureSEC source: 0001193125-26-290902 · ownership.xml · nonDerivative · entry 3 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 21:45 UTC |
Yu Jonathan Yen-WenChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0001193125-26-290891 · ownership.xml · derivative · entry 3 Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,847 Underlying: Common Stock · 300 shares Expires 2032-12-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026. F2 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 21:45 UTC |
Yu Jonathan Yen-WenChief Operating Officer
|
SaleCommon Stock | 300 | $72.50 | $21,750.00 |
DisclosureSEC source: 0001193125-26-290891 · ownership.xml · nonDerivative · entry 2 Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,324 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 21:45 UTC |
Yu Jonathan Yen-WenChief Operating Officer
|
Exercise / conversionCommon Stock | 300 | $13.50 | $4,050.00 |
DisclosureSEC source: 0001193125-26-290891 · ownership.xml · nonDerivative · entry 1 Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 21:49 UTC |
Khara RahulChief Legal Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 851 | $0.00 Strike: $14.69 | $0.00 |
DisclosureSEC source: 0001193125-26-290902 · ownership.xml · derivative · entry 5 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,453 Underlying: Common Stock · 851 shares Expires 2032-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 21:49 UTC |
Khara RahulChief Legal Officer
|
SaleCommon Stock | 851 | $75.00 | $63,825.00 |
DisclosureSEC source: 0001193125-26-290902 · ownership.xml · nonDerivative · entry 2 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,173 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 21:49 UTC |
Khara RahulChief Legal Officer
|
Exercise / conversionCommon Stock | 851 | $14.69 | $12,501.19 |
DisclosureSEC source: 0001193125-26-290902 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 00:34 UTC |
Yu Jonathan Yen-WenChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,700 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0001193125-26-281519 · ownership.xml · derivative · entry 3 Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,147 Underlying: Common Stock · 9,700 shares Expires 2032-12-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026. F3 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 00:34 UTC |
Yu Jonathan Yen-WenChief Operating Officer
|
SaleCommon Stock | 9,700 | $72.66 | $704,795.21 |
DisclosureSEC source: 0001193125-26-281519 · ownership.xml · nonDerivative · entry 2 Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,324 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.50 to $72.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 00:34 UTC |
Yu Jonathan Yen-WenChief Operating Officer
|
Exercise / conversionCommon Stock | 9,700 | $13.50 | $130,950.00 |
DisclosureSEC source: 0001193125-26-281519 · ownership.xml · nonDerivative · entry 1 Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:16 UTC |
Quisel John DDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 34,000 | $0.00 Strike: $9.86 | $0.00 |
DisclosureSEC source: 0001193125-26-279779 · ownership.xml · derivative · entry 5 Quisel John D · CIK 0001586788 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,375 Underlying: Common Stock · 34,000 shares Expires 2031-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026. F5 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:16 UTC |
Quisel John DDirector · Chief Executive Officer
|
SaleCommon Stock | 1,551 | $71.61 | $111,071.14 |
DisclosureSEC source: 0001193125-26-279779 · ownership.xml · nonDerivative · entry 4 Quisel John D · CIK 0001586788 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 226,064 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.36 to $71.85, inclusive. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:16 UTC |
Quisel John DDirector · Chief Executive Officer
|
SaleCommon Stock | 9,522 | $70.70 | $673,205.40 |
DisclosureSEC source: 0001193125-26-279779 · ownership.xml · nonDerivative · entry 3 Quisel John D · CIK 0001586788 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 227,615 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.36 to $71.35, inclusive. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:16 UTC |
Quisel John DDirector · Chief Executive Officer
|
SaleCommon Stock | 22,927 | $69.92 | $1,603,019.16 |
DisclosureSEC source: 0001193125-26-279779 · ownership.xml · nonDerivative · entry 2 Quisel John D · CIK 0001586788 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 237,137 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.35 to $70.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:16 UTC |
Quisel John DDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 34,000 | $9.86 | $335,240.00 |
DisclosureSEC source: 0001193125-26-279779 · ownership.xml · nonDerivative · entry 1 Quisel John D · CIK 0001586788 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 260,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2026. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:21 UTC |
Khara RahulChief Legal Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $14.69 | $0.00 |
DisclosureSEC source: 0001193125-26-279792 · ownership.xml · derivative · entry 5 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,304 Underlying: Common Stock · 7,500 shares Expires 2032-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F5 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:21 UTC |
Khara RahulChief Legal Officer
|
SaleCommon Stock | 500 | $71.62 | $35,811.00 |
DisclosureSEC source: 0001193125-26-279792 · ownership.xml · nonDerivative · entry 4 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,173 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.45 to $71.81, inclusive. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:21 UTC |
Khara RahulChief Legal Officer
|
SaleCommon Stock | 1,600 | $70.73 | $113,161.12 |
DisclosureSEC source: 0001193125-26-279792 · ownership.xml · nonDerivative · entry 3 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,673 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.40 to $71.38, inclusive. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:21 UTC |
Khara RahulChief Legal Officer
|
SaleCommon Stock | 5,400 | $69.94 | $377,688.42 |
DisclosureSEC source: 0001193125-26-279792 · ownership.xml · nonDerivative · entry 2 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,273 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.35 to $70.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:21 UTC |
Khara RahulChief Legal Officer
|
Exercise / conversionCommon Stock | 7,500 | $14.69 | $110,175.00 |
DisclosureSEC source: 0001193125-26-279792 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 20:59 UTC |
GEMAYEL GEORGESDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,212 | $0.00 Strike: $70.79 | $0.00 |
DisclosureSEC source: 0001193125-26-279712 · ownership.xml · derivative · entry 1 GEMAYEL GEORGES · CIK 0001256088 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,212 Underlying: Common Stock · 6,212 shares Expires 2036-06-17 F1 · derivative.exercise_date: The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:04 UTC |
White William RichardDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,212 | $0.00 Strike: $70.79 | $0.00 |
DisclosureSEC source: 0001193125-26-279742 · ownership.xml · derivative · entry 1 White William Richard · CIK 0001778739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,212 Underlying: Common Stock · 6,212 shares Expires 2036-06-17 F1 · derivative.exercise_date: The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:01 UTC |
Ratcliffe LiamDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,212 | $0.00 Strike: $70.79 | $0.00 |
DisclosureSEC source: 0001193125-26-279734 · ownership.xml · derivative · entry 1 Ratcliffe Liam · CIK 0001547100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,212 Underlying: Common Stock · 6,212 shares Expires 2036-06-17 F1 · derivative.exercise_date: The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:00 UTC |
Nicholson Donald WilliamDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,212 | $0.00 Strike: $70.79 | $0.00 |
DisclosureSEC source: 0001193125-26-279732 · ownership.xml · derivative · entry 1 Nicholson Donald William · CIK 0001814617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,212 Underlying: Common Stock · 6,212 shares Expires 2036-06-17 F1 · derivative.exercise_date: The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 20:58 UTC |
Chin MarkDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,212 | $0.00 Strike: $70.79 | $0.00 |
DisclosureSEC source: 0001193125-26-279708 · ownership.xml · derivative · entry 1 Chin Mark · CIK 0001734389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,212 Underlying: Common Stock · 6,212 shares Expires 2036-06-17 F1 · derivative.exercise_date: The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 20:56 UTC |
Bitterman KevinDirector
|
GrantStock Option (Right to Buy) · Derivative | 6,212 | $0.00 Strike: $70.79 | $0.00 |
DisclosureSEC source: 0001193125-26-279705 · ownership.xml · derivative · entry 1 Bitterman Kevin · CIK 0001591747 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,212 Underlying: Common Stock · 6,212 shares Expires 2036-06-17 F1 · derivative.exercise_date: The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. F2 · ownership.direct: This option was granted to the Reporting Person, a director of the Issuer. The proceeds of any sale of shares of common stock issued to the Reporting Person upon exercise of this option will be transferred to Atlas Venture Life Science Advisors, LLC and as such, the Reporting Person disclaims ownership of such securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 20:54 UTC |
AHMED NADIMDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,176 | $0.00 Strike: $70.79 | $0.00 |
DisclosureSEC source: 0001193125-26-279690 · ownership.xml · derivative · entry 1 AHMED NADIM · CIK 0001731193 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,176 Underlying: Common Stock · 5,176 shares Expires 2036-06-17 F1 · derivative.exercise_date: The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:43 UTC |
Yu Jonathan Yen-WenChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,351 | $0.00 Strike: $9.86 | $0.00 |
DisclosureSEC source: 0001193125-26-275996 · ownership.xml · derivative · entry 6 Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,951 Underlying: Common Stock · 13,351 shares Expires 2031-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026. F4 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:43 UTC |
Yu Jonathan Yen-WenChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,261 | $0.00 Strike: $9.86 | $0.00 |
DisclosureSEC source: 0001193125-26-275996 · ownership.xml · derivative · entry 5 Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,753 Underlying: Common Stock · 5,261 shares Expires 2031-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026. F4 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:43 UTC |
Yu Jonathan Yen-WenChief Operating Officer
|
SaleCommon Stock | 6,961 | $69.92 | $486,699.20 |
DisclosureSEC source: 0001193125-26-275996 · ownership.xml · nonDerivative · entry 4 Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,324 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.40 to $70.19, inclusive. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:43 UTC |
Yu Jonathan Yen-WenChief Operating Officer
|
SaleCommon Stock | 11,651 | $68.76 | $801,101.79 |
DisclosureSEC source: 0001193125-26-275996 · ownership.xml · nonDerivative · entry 3 Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,285 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.37 to $69.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:43 UTC |
Yu Jonathan Yen-WenChief Operating Officer
|
Exercise / conversionCommon Stock | 13,351 | $9.86 | $131,640.86 |
DisclosureSEC source: 0001193125-26-275996 · ownership.xml · nonDerivative · entry 2 Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:43 UTC |
Yu Jonathan Yen-WenChief Operating Officer
|
Exercise / conversionCommon Stock | 5,261 | $9.86 | $51,873.46 |
DisclosureSEC source: 0001193125-26-275996 · ownership.xml · nonDerivative · entry 1 Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 20:53 UTC |
Franchi Jean M.Chief Financial Officer
|
SaleCommon Stock | 6,257 | $69.24 | $433,234.05 |
DisclosureSEC source: 0001193125-26-157187 · ownership.xml · nonDerivative · entry 2 Franchi Jean M. · CIK 0001653053 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,333 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.07 to $69.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| April 13, 2026 Filed Apr 15, 2026 21:05 UTC |
Savage William JacobChief Medical Officer
|
SaleCommon Stock | 2,200 | $66.81 | $146,976.06 |
DisclosureSEC source: 0001193125-26-157215 · ownership.xml · nonDerivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,480 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.57 to $67.00, inclusive. Read SEC document |
| April 13, 2026 Filed Apr 15, 2026 21:05 UTC |
Savage William JacobChief Medical Officer
|
SaleCommon Stock | 3,531 | $66.12 | $233,472.90 |
DisclosureSEC source: 0001193125-26-157215 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,680 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.50 to $66.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| April 13, 2026 Filed Apr 15, 2026 20:53 UTC |
Franchi Jean M.Chief Financial Officer
|
SaleCommon Stock | 400 | $69.00 | $27,600.00 |
DisclosureSEC source: 0001193125-26-157187 · ownership.xml · nonDerivative · entry 1 Franchi Jean M. · CIK 0001653053 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,590 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:55 UTC |
Savage William JacobChief Medical Officer
|
SaleCommon Stock | 2,986 | $66.41 | $198,297.27 |
DisclosureSEC source: 0001193125-26-091757 · ownership.xml · nonDerivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,211 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.03 to $66.88, inclusive. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:55 UTC |
Savage William JacobChief Medical Officer
|
SaleCommon Stock | 4,392 | $65.52 | $287,771.75 |
DisclosureSEC source: 0001193125-26-091757 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,197 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:49 UTC |
Franchi Jean M.Chief Financial Officer
|
SaleCommon Stock | 353 | $69.06 | $24,377.09 |
DisclosureSEC source: 0001193125-26-083027 · ownership.xml · nonDerivative · entry 1 Franchi Jean M. · CIK 0001653053 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,990 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.00 to $69.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 22:42 UTC |
Franchi Jean M.Chief Financial Officer
|
SaleCommon Stock | 3,684 | $65.89 | $242,734.71 |
DisclosureSEC source: 0001193125-26-059760 · ownership.xml · nonDerivative · entry 3 Franchi Jean M. · CIK 0001653053 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,343 F2 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.51 to $66.38, inclusive. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 22:42 UTC |
Franchi Jean M.Chief Financial Officer
|
SaleCommon Stock | 3,397 | $65.01 | $220,837.95 |
DisclosureSEC source: 0001193125-26-059760 · ownership.xml · nonDerivative · entry 2 Franchi Jean M. · CIK 0001653053 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,027 F2 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.47 to $65.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 02:20 UTC |
Khara RahulChief Legal Officer
|
SaleCommon Stock | 2,853 | $62.86 | $179,339.58 |
DisclosureSEC source: 0001193125-26-055652 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,173 F1 · kind: This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 02:09 UTC |
Savage William JacobChief Medical Officer
|
SaleCommon Stock | 3,256 | $62.86 | $204,672.16 |
DisclosureSEC source: 0001193125-26-055630 · ownership.xml · nonDerivative · entry 1 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,589 F1 · kind: This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 02:15 UTC |
Stephenson PamelaChief Commercial Officer
|
SaleCommon Stock | 5,531 | $62.86 | $347,678.66 |
DisclosureSEC source: 0001193125-26-055646 · ownership.xml · nonDerivative · entry 1 Stephenson Pamela · CIK 0001767650 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,998 F1 · kind: This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 02:05 UTC |
Yu Jonathan Yen-WenChief Operating Officer
|
SaleCommon Stock | 3,231 | $62.86 | $203,100.66 |
DisclosureSEC source: 0001193125-26-055626 · ownership.xml · nonDerivative · entry 1 Yu Jonathan Yen-Wen · CIK 0001951849 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,324 F1 · kind: This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 02:03 UTC |
Quisel John DDirector · Chief Executive Officer
|
SaleCommon Stock | 13,264 | $62.86 | $833,775.04 |
DisclosureSEC source: 0001193125-26-055623 · ownership.xml · nonDerivative · entry 1 Quisel John D · CIK 0001586788 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,064 F1 · kind: This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.